[HTML][HTML] Molnupiravir: A versatile prodrug against SARS-CoV-2 variants

D Teli, P Balar, K Patel, A Sharma, V Chavda, L Vora - Metabolites, 2023 - mdpi.com
The nucleoside analog β-DN 4-hydroxycytidine is the active metabolite of the prodrug
molnupiravir and is accepted as an efficient drug against COVID-19. Molnupiravir targets the …

Molnupiravir: A Versatile Prodrug against SARS-CoV-2 Variants.

D Teli, P Balar, K Patel, A Sharma… - Metabolites (2218 …, 2023 - search.ebscohost.com
The nucleoside analog β-D-N4-hydroxycytidine is the active metabolite of the prodrug
molnupiravir and is accepted as an efficient drug against COVID-19. Molnupiravir targets the …

Molnupiravir: a versatile prodrug against SARS-CoV-2 variants

D Teli, P Balar, K Patel, A Sharma, V Chavda, L Vora… - Metabolites, 2023 - pure.qub.ac.uk
The nucleoside analog β-D-N4-hydroxycytidine is the active metabolite of the prodrug
molnupiravir and is accepted as an efficient drug against COVID-19. Molnupiravir targets the …

Molnupiravir: A Versatile Prodrug against SARS-CoV-2 Variants

D Teli, P Balar, K Patel, A Sharma, V Chavda… - …, 2023 - pubmed.ncbi.nlm.nih.gov
The nucleoside analog β-D-N4-hydroxycytidine is the active metabolite of the prodrug
molnupiravir and is accepted as an efficient drug against COVID-19. Molnupiravir targets the …

[HTML][HTML] Molnupiravir: A Versatile Prodrug against SARS-CoV-2 Variants

D Teli, P Balar, K Patel, A Sharma, V Chavda, L Vora - Metabolites, 2023 - ncbi.nlm.nih.gov
The nucleoside analog β-D-N4-hydroxycytidine is the active metabolite of the prodrug
molnupiravir and is accepted as an efficient drug against COVID-19. Molnupiravir targets the …

Molnupiravir: A Versatile Prodrug against SARS-CoV-2 Variants.

D Teli, P Balar, K Patel, A Sharma, V Chavda, L Vora - Metabolites, 2023 - europepmc.org
The nucleoside analog β-D-N4-hydroxycytidine is the active metabolite of the prodrug
molnupiravir and is accepted as an efficient drug against COVID-19. Molnupiravir targets the …

Molnupiravir: A Versatile Prodrug against SARS-CoV-2 Variants

D Teli, P Balar, K Patel, A Sharma, V Chavda… - …, 2023 - search.proquest.com
The nucleoside analog β-D-N4-hydroxycytidine is the active metabolite of the prodrug
molnupiravir and is accepted as an efficient drug against COVID-19. Molnupiravir targets the …